Representative before the EPO

Company dna probiodrug ag
no operation time available
Headquarter in Halle (Saale)
active in Legal Services

Representative before the EPO

Employment test 11 - 50 employees
Company dna maikowski and ninnemann
operating since 1989
Headquarter in Berlin and 2 offices
active in Legal Services and IP Portfolio Processing

We have observed 18 EP applications Matthias Hoffmann has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12708855

DIAGNOSTIC ANTIBODY ASSAY

IPC classification:
C07K 16/18, G01N 33/68
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP12709323

BENZ IMIDAZOLE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE

IPC classification:
A61K 31/4184, A61P 25/28, C07D 401/14, C07D 403/04, C07D 413/14, C07D 417/14
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11864435

USE OF REGULATOR OF CALCINEURIN 1 FOR MANUFACTURING MEDICAMENT FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASED NF- B ACTIVITY

IPC classification:
A61K 38/55, A61P 35/00
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723476

RADIOLABELLED GLUTAMINYL CYCLASE INHIBITORS

IPC classification:
A61K 51/04, A61K 101/00
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP12857495

A METHOD OF ANTIBODY PURIFICATION

IPC classification:
C07K 1/18, C07K 1/20, C07K 1/34, C07K 16/28
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP12790483

INHALATION SUPPORT APPARATUS AND METHOD FOR INHALATION SUPPORT

IPC classification:
A61B 5/08, A61M 15/00, A63B 23/18
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP11800122

PHARMACEUTICAL COMPOSITION COMPRISING LEVOCARNITINE AND DOBESILATE

IPC classification:
A61K 31/095, A61K 31/185, A61K 31/205, A61P 9/00, A61P 9/10, A61P 13/12
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761564

AN EXPRESSION VECTOR COMPRISING A POLYNUCLEOTIDE ENCODING A MODIFIED GLUTAMINE SYNTHETASE AND A METHOD FOR PREPARING A TARGET PROTEIN EMPLOYING THE SAME

IPC classification:
C12N 9/00, C12N 15/52, C12N 15/85
Applicant:
Ares Trading SA
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Agent:
Merck Serono S.A.
Status:
EXAMINATION IN PROGRESS
EP13187703

Method for adapting decorative prints and device for carrying out said method

IPC classification:
B41J 3/407, B41M 5/00
Applicant:
Flooring Technologies Ltd.
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14194326

Thiourea derivatives as glutaminyl cyclase inhibitors

IPC classification:
A61K 31/4164, A61K 31/4184, A61P 25/00, C07D 233/54, C07D 235/06, C07D 401/12, C07D 405/12, C07D 409/12, C07D 413/12, C07D 417/12
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP13813388

NOVEL MONOCLONAL ANTIBODY BINDING SPECIFICALLY TO DLL4 AND USE THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP13194476

New mineral binder and the use thereof for the manufacturing of wood-based panels

IPC classification:
B27N 3/10, C04B 20/10, C04B 28/00, C04B 41/50, C04B 111/00, D21J 1/08, E04C 2/10
Applicant:
Kronotec AG
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP11703712

METHODS OF DIAGNOSING INFLAMMATORY DISEASES BY DETERMINING PYROGLUTAMATE-MODIFIED MCP-1 AND SCREENING METHODS FOR INHIBITORS OF GLUTAMINYL CYCLASE

IPC classification:
G01N 33/574, G01N 33/68
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION WITHDRAWN
EP14152417

New fusion gene as therapeutic target in proliferative diseases

IPC classification:
C07K 14/435
Applicant:
Technische Universität Dresden KöR
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
EXAMINATION IN PROGRESS
EP11707182

HETEROCYCLIC INHIBITORS OF GLUTAMINYL CYCLASE (QC, EC 2.3.2.5)

IPC classification:
A61K 31/4184, A61K 31/454, A61K 31/4709, A61K 31/5377, A61P 1/04, A61P 25/18, A61P 25/28, A61P 29/00, A61P 31/04, A61P 35/00, C07D 401/04, C07D 403/04, C07D 403/10, C07D 403/14, C07D 405/10
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11745800

CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE

IPC classification:
C12N 9/10, G06F 19/16
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11708026

INHIBITORS OF PROTEIN KINASES

IPC classification:
A61K 31/44, A61K 31/4418, A61K 31/4436, A61K 31/4439, A61K 31/4545, A61K 31/496, A61P 9/00, A61P 25/00, A61P 25/28, A61P 29/00, C07D 213/75, C07D 401/12, C07D 401/14, C07D 409/12, C07D 417/12
Applicant:
AstraZeneca AB
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11776434

CRYSTAL STRUCTURE OF ISOGLUTAMINYL CYCLASE

IPC classification:
C12N 9/10, G06F 19/16
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature